4//SEC Filing
Trowbridge Stephen A 4
Accession 0001140361-25-026462
CIK 0001275187other
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 6:06 PM ET
Size
17.5 KB
Accession
0001140361-25-026462
Insider Transaction Report
Form 4
Trowbridge Stephen A
SVP and General Counsel
Transactions
- Award
Common Stock
2025-07-16+86,997→ 259,708 total - Award
Performance Right
2025-07-16+86,997→ 86,997 total→ Common Stock (86,997 underlying)
Footnotes (2)
- [F1]The acquisition of 86,997 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 86,997 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 16, 2026, such that 25% of the restricted stock units will vest on each of July 16, 2026, 2027, 2028 and 2029.
- [F2]Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited.
Documents
Issuer
ANGIODYNAMICS INC
CIK 0001275187
Entity typeother
Related Parties
1- filerCIK 0001624250
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 6:06 PM ET
- Size
- 17.5 KB